Pancreatic Cancer Research

ResearcherShandong UniversityNo recent work listed

Shihong Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5488-2139; OpenAlex author ID A5100731247. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers

Papers 3

  1. Oligoadenylate synthetases-like is a prognostic biomarker and therapeutic target in pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/atm-21-6618↗
  2. LncRNA SNHG1 Promotes the Progression of Pancreatic Cancer by Regulating FGFR1 Expression via Competitively Binding to miR-497. Co-author DOI 10.3389/fonc.2022.813850↗
  3. Plasma-Derived Exosome MiR-19b Acts as a Diagnostic Marker for Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.739111↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianwei Xu · 2 shared papers, 2021–2022 · strength 0.32
  2. Lei Wang · 1 shared paper, 2022 · strength 0.16
  3. Lei Wang · 1 shared paper, 2021 · strength 0.15
  4. Hanxiang Zhan · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.